{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreid4yjkv6aoas3txtkr66553g6pceuqylwcfzemj3soekpmjnob6ue",
    "uri": "at://did:plc:k7h5fn3kdhjpj37pc6yhno2o/app.bsky.feed.post/3mj3mzugclyc2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreiao5lbfx77g2znevrykyl6xtdg27vaaha7rnznutukfp52lqxzr2y"
    },
    "mimeType": "image/jpeg",
    "size": 135877
  },
  "path": "/article/lyme-disease-is-spreading-but-a-new-vaccine-could-curb-infections/",
  "publishedAt": "2026-04-09T12:00:00.000Z",
  "site": "https://www.scientificamerican.com",
  "textContent": "A new Lyme disease vaccine made by Pfizer and Valneva could lower infection rates of the tick-borne illness, but federal approval and patient uptake could be a challenge",
  "title": "Lyme disease is spreading, but a new vaccine could curb infections"
}